Dexcom Inc
DXCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001093557
In the last 90 days, Dexcom Inc insiders filed 0 open-market purchases and 9 sales; 982 institutions reported holding it in 13F filings for Q2 2026, worth $26.0B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 30, 2026, 1:16 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Cost of revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768.0M |
| Gross profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B |
| Operating expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B |
| Research and development | $599.1M | $552.4M | $505.8M | $484.2M | $517.1M |
| Selling, general and administrative | $1.29B | $1.29B | $1.19B | $1.00B | $810.5M |
| Operating income | $911.8M | $600.0M | $597.7M | $391.2M | $265.8M |
| Interest expense | $14.3M | $14.9M | $20.3M | $18.6M | $100.3M |
| Income tax | $252.1M | $132.8M | $168.9M | $49.6M | $19.2M |
| Net income | $836.3M | $576.2M | $541.5M | $341.2M | $154.7M |
| EPS, basic | $2.14 | $1.46 | $1.40 | $0.88 | $1.60 |
| EPS, diluted | $2.09 | $1.42 | $1.30 | $0.82 | $1.55 |
| Weighted shares, basic | 390.2M | 393.6M | 386.0M | 389.4M | 96.7M |
| Weighted shares, diluted | 405.5M | 412.7M | 425.5M | 427.5M | 100.1M |
| Margins and growth | |||||
| Gross margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Operating margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Net margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% |
| Revenue growth, year over year | +15.6% | +11.3% | +24.5% | +18.8% | +27.1% |
| Net income growth, year over year | +45.1% | +6.4% | +58.7% | +120.6% | −68.7% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Cash and equivalents | $917.7M | $606.1M | $566.3M | $642.3M | $1.05B |
| Accounts receivable | $1.22B | $1.01B | $973.9M | $713.3M | $514.3M |
| Inventory | $629.1M | $542.6M | $559.6M | $306.7M | $357.3M |
| Total current assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B |
| Property, plant and equipment | – | – | – | – | $801.8M |
| Goodwill | $24.2M | $22.8M | $25.2M | $25.7M | $26.5M |
| Intangible assets | $70.8M | $103.4M | $134.5M | $173.3M | – |
| Total assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.86B |
| Total current liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $720.8M |
| Total liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.61B |
| Shareholders' equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.25B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Operating cash flow | $1.44B | $989.5M | $748.5M | $669.5M | $442.5M |
| Capital expenditures | $363.5M | $358.8M | $236.6M | $364.8M | $389.2M |
| Free cash flow | $1.08B | $630.7M | $511.9M | $304.7M | $53.3M |
| Depreciation and amortization | $251.8M | $217.7M | $186.0M | $155.9M | $102.0M |
| Stock-based compensation | $159.6M | $170.4M | $150.8M | $126.5M | $113.4M |
| Share buybacks | $500.0M | $750.0M | $688.7M | $557.7M | – |
| Investing cash flow | $536.0M | -$207.5M | -$507.2M | -$521.5M | -$216.1M |
| Financing cash flow | -$1.69B | -$734.8M | -$318.6M | -$552.5M | $10.4M |
| Net change in cash | $311.8M | $39.8M | -$75.8M | -$410.3M | $235.4M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 3.4% | 4.2% | 4.2% | 4.3% | 4.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 22, 2026 | 373.0M | −4.4% | SEC |
| Jul 23, 2026 | 377.4M | −3.8% | SEC |
| Apr 23, 2026 | 385.9M | −1.6% | SEC |
| Feb 5, 2026 | 384.9M | −1.5% | SEC |
| Oct 23, 2025 | 390.0M | −0.1% | SEC |
| Jul 23, 2025 | 392.2M | −2.1% | SEC |
| Apr 24, 2025 | 392.1M | −1.4% | SEC |
| Feb 6, 2025 | 390.8M | +1.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Dec 31, 2020, from 13F share counts: 4-for-1 in Q2 2022.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.